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The endosomal trafficking protein Rab27a supports HIV-1 replication by promoting PI(4,5)P~2~ production at the plasma membrane (PM), Pereyra Gerber et al. reveal.

New HIV-1 particles assemble at specialized PM domains that are enriched in the phospholipid PI(4,5)P~2~ and recruit the viral polyprotein Pr55^Gag^. Because endosomal trafficking has been implicated in viral assembly and release, Pereyra Gerber et al. investigated whether HIV-1 replication was controlled by Rab27a, a small GTPase that promotes the delivery of late endosomes and multivesicular bodies to the PM.

Viral replication was impaired in T cells lacking Rab27a, the researchers found. These cells showed reduced levels of PI(4,5)P~2~ at the PM and thus failed to recruit Pr55^Gag^ to form viral assembly sites. Knocking down Rab27a also suppressed PI(4,5)P~2~ production and viral replication in macrophages, which normally recruit Pr55^Gag^ to PM invaginations called virus-containing compartments.

Rab27a boosted PI(4,5)P~2~ production at the PM by delivering the late endosome-associated lipid kinase PI4KIIα, which generates the PI(4,5)P~2~ precursor PI(4)P. Several Rab27a effectors were also required for HIV-1 replication. T cells lacking the endosomal docking protein Slp2a, for example, also failed to deliver PI4KIIα to the PM to promote PI(4,5)P~2~ production and Pr55^Gag^ recruitment.

Senior author Matías Ostrowski says that these results open a path to investigate whether manipulating endosomal traffic could be a new target for anti--HIV-1 therapies. He now wants to investigate how endosomes carrying PI4KIIα fuse with the PM once they have been docked there by Rab27a and its effectors.
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